Profile data is unavailable for this security.
About the company
Joinn Laboratories China Co Ltd is a China-based company primarily engaged in the pharmacology and toxicology research of new drugs. Non-clinical research services include drug safety evaluation, pharmacokinetic research as well as pharmacological and pharmacodynamic research. Clinical trials and related services include clinical contract research organization services, phase I clinical research collaboration unit (CRU), and bioanalysis services. Experimental model business mainly includes rodents and non-human primates. The Company conducts its businesses both in the domestic market and overseas markets.
- Revenue in CNY (TTM)1.59bn
- Net income in CNY589.45m
- Incorporated1998
- Employees2.14k
- LocationJoinn Laboratories China Co LtdA5 Rongjing East StreetEconomic-Technological Development AreaBEIJING 100176ChinaCHN
- Phone+86 1 067869582
- Fax+86 1 067869966
- Websitehttp://www.joinn-lab.com/
More ▼
Mergers & acquisitions
| Acquired company | 603127:SHH since announced | Transaction value |
|---|---|---|
| Guangxi Weimei Bio-Tech Co Ltd | -13.00% | 147.13m |
| Yunnan Yinmore Bio-Tech Co Ltd | -13.00% | 125.23m |
Data delayed at least 15 minutes, as of Aug 15 2022 08:00 BST.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| China Southern Pwr Grd Technology Co Ltd | 1.48bn | 158.49m | 22.40bn | 330.00 | 142.87 | 9.30 | -- | 15.26 | 0.2807 | 0.2807 | 2.63 | 4.31 | -- | -- | -- | 4,496,127.00 | -- | -- | -- | -- | 29.18 | -- | 10.68 | -- | 4.34 | -- | 0.0601 | -- | 24.28 | -- | 64.25 | -- | -- | -- |
| Milkyway Chemical Sply Chn Srvce Co Ltd | 11.45bn | 552.24m | 23.07bn | 3.36k | 42.20 | 6.68 | -- | 2.03 | 3.35 | 3.35 | 69.66 | 21.18 | 1.65 | 100.72 | 6.10 | 3,407,257.00 | 8.11 | 8.55 | 14.18 | 13.70 | 9.90 | 14.04 | 4.91 | 6.47 | 1.35 | 16.46 | 0.477 | 13.79 | 152.26 | 55.89 | 49.67 | 50.44 | 47.27 | -- |
| Wuchan Zhongda Group Co Ltd | 575.78bn | 3.96bn | 24.10bn | 21.01k | 5.93 | 0.7409 | -- | 0.0415 | 0.7763 | 0.7763 | 112.75 | 6.21 | 3.78 | 12.82 | 43.73 | 27,402,540.00 | 3.93 | 4.23 | 15.33 | 12.44 | 2.60 | 2.62 | 1.04 | 1.06 | 0.671 | -- | 0.5684 | 38.63 | 39.25 | 22.11 | 46.91 | 15.18 | 17.88 | -13.65 |
| CNOOC Energy Technology & Services Ltd | 40.39bn | 1.37bn | 25.21bn | 14.93k | 18.49 | 1.22 | -- | 0.6217 | 0.1336 | 0.1336 | 4.09 | 2.03 | 1.25 | 37.61 | 4.28 | 2,706,025.00 | 4.55 | 4.48 | 6.84 | 7.44 | 12.77 | 12.88 | 3.63 | 4.21 | 1.52 | -- | 0.0596 | 22.17 | 16.66 | 14.86 | -15.65 | 15.59 | 13.50 | -- |
| Joinn Laboratories China Co Ltd | 1.59bn | 589.45m | 38.86bn | 2.14k | 66.29 | 5.58 | -- | 23.82 | 1.14 | 1.14 | 2.95 | 13.61 | 0.1913 | 1.18 | 9.79 | 741,431.30 | 7.09 | 12.17 | 8.29 | 16.55 | 48.29 | 50.84 | 37.07 | 31.49 | 3.52 | -- | 0.012 | 27.82 | 40.97 | 44.37 | 76.96 | 60.90 | 35.25 | -- |
Data as of Aug 15 2022. Currency figures normalised to Joinn Laboratories China Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
15.32%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Zhong Ou Asset Management Co., Ltdas of 31 Dec 2021 | 17.88m | 5.58% |
| China Universal Asset Management Co., Ltd.as of 31 Dec 2021 | 7.55m | 2.36% |
| GF Fund Management Co., Ltd.as of 31 Dec 2021 | 4.32m | 1.35% |
| ICBC Credit Suisse Asset Management Co., Ltd.as of 31 Dec 2021 | 4.24m | 1.32% |
| Harvest Fund Management Co., Ltd.as of 31 Dec 2021 | 3.83m | 1.19% |
| China Southern Asset Management Co., Ltd.as of 31 Dec 2021 | 3.77m | 1.18% |
| China Merchants Fund Management Co., Ltd.as of 31 Dec 2021 | 3.36m | 1.05% |
| Hwabao WP Fund Management Co., Ltd.as of 31 Dec 2021 | 1.87m | 0.59% |
| Galaxy Asset Management Co., Ltd.as of 31 Dec 2021 | 1.15m | 0.36% |
| Cinda Fund Management Co. Ltd.as of 31 Dec 2021 | 1.11m | 0.35% |
More ▼
Data from 31 Dec 2021 - 30 Jun 2022Source: FactSet Research Systems Inc.
